Old drug, new use: Recent advances for G-CSF

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Granulocyte colony-stimulating factor (G-CSF), also known as colony-stimulating factor 3 (CSF3), is a proinflammatory cytokine.
• It primarily stimulates neutrophil granulocyte progenitor cells and mature neutrophils, impacting their survival, proliferation, differentiation, and function.

Purpose of the Study:

• To review the structure, functions, mechanisms, and clinical applications of G-CSF.
• To highlight recent findings on G-CSF's roles beyond traditional uses.

Main Methods:

• Literature review focusing on G-CSF structure, neutrophil dynamics, immunoregulation, and clinical studies.
• Analysis of existing research on G-CSF's therapeutic potential.

Main Results:

• G-CSF is crucial for neutrophil homeostasis and has established roles in treating neutropenia and leukemia.
• Recent studies indicate G-CSF's utility in conditioning regimens and prophylaxis post-allogeneic transplantation, improving patient survival.
• G-CSF also exhibits immunoregulation and can influence solid tumor proliferation.

Conclusions:

• G-CSF is a versatile cytokine with established and emerging therapeutic applications.
• Its multifaceted roles in neutrophil biology, transplantation, and cancer warrant further investigation.
• Understanding G-CSF's mechanisms can lead to novel clinical strategies.